Dextrose Injection USP recalled due to sterility assurance concerns
B. Braun Medical Inc. is recalling Dextrose Injection USP 70% in 2000 mL bags nationwide due to lack of assurance of sterility and potential leakage from the diaphragm port after foil removal.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall of a sterile injectable drug with potential for microbial contamination (lack of sterility assurance) and product leakage—hazards that could result in serious adverse health consequences including infection in vulnerable patients receiving intravenous therapy.
Plain-English summary
B. Braun Medical Inc. is recalling Dextrose Injection USP, 70%, in 2000 mL bags (NDC: 0264-7387-50) nationwide. The recall affects 17,124 bags from Lots J5H166 and J5H167 with an expiration date of November 30, 2026.
The product is being recalled due to lack of assurance of sterility and potential for leakage from the diaphragm port once the foil is removed. This intravenous medication is distributed nationwide.
Patients and healthcare providers who have this product should not use affected lots. Contact B. Braun Medical Inc. or the FDA for guidance on proper handling and replacement options.
The recalled product
- Product
- DEXTROSE (DEXTROSE)
- Brand
- DEXTROSE
- Manufacturer
- B BRAUN MEDICAL INC
- Category
- Drug — Intravenous Injection
- Affected units
- 17,124
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot # J5H166
- J5H167
- Exp Date: 30NOV2026.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by B BRAUN MEDICAL INC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same brand · DEXTROSE
- HighFresenius Kabi 5% dextrose injection bags recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- HighFresenius Kabi 50 mL dextrose injection bags recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- HighFresenius Kabi 100 mL dextrose injection bags recalled over sterility assurance
FDA (Drugs) · 2026-04-15
- SeverePfizer 5% Dextrose Injection Recalled for Potential Bag Leakage
FDA (Drugs) · 2021-12-08
- ModeratePfizer Recalls Dextrose Injection Due to Incorrect Expiration Date Labeling
FDA (Drugs) · 2019-12-18
Same manufacturer · B BRAUN MEDICAL INC
See all →- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- ModerateB. Braun UPMC double catheter trays contain Mastisol with cracking tubing
FDA (Devices) · 2026-06-10
- ModerateB. Braun Shands kits contain Mastisol adhesive with cracking tubing
FDA (Devices) · 2026-06-10
- ModerateB. Braun spinal epidural kits contain Mastisol with cracking tubing
FDA (Devices) · 2026-06-10
- ModerateB. Braun kits contain Mastisol adhesive with potentially cracking tubing
FDA (Devices) · 2026-06-10
Same hazard · sterility assurance
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
- SevereArrow access trays and PSI kits contain recalled supplier drugs
FDA (Devices) · 2026-06-24